FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Oncologic Panel to Review Multiple Myeloma BLA

[ Price : $8.95]

FDA schedules a 7/17 meeting of its Oncologic Drugs Advisory Committee to review and vote on a GSK BLA for Blenrep (belantamab maf...

Medtronic Newport Ventilator Recall Class 1

[ Price : $8.95]

FDA says a Medtronic recall of specified Newport ventilators is Class 1.

Questions Raised on New ACIP Members

[ Price : $8.95]

The Associated Press reports that questions are being raised about some new members appointed to the CDC Advisory Committee on Imm...

Capricor Gets Form-483 After BLA Facility Inspection

[ Price : $8.95]

A recent FDA pre-license inspection of Capricor Therapeutics San Diego manufacturing facility for investigation cell therapy Deram...

FDA Approves UroGen Bladder Cancer Therapy

[ Price : $8.95]

FDA approves a UroGen Pharma NDA for Zusduri (mitomycin intravesical solution) for adult patients with recurrent low-grade interme...

Viz.ai Subdural Hemorrhage Quantifier Cleared

[ Price : $8.95]

FDA clears a Viz.ai 510(k) for the Viz Subdural Plus, which the company describes as the first and only comprehensive solution for...

Researchers Challenge FDA Lamictal Safety Warning

[ Price : $8.95]

Rutgers University researchers say they have determined that the GlaxoSmithKline anti-seizure drug Lamictal is safe for adults wit...

More FDA Operational Changes Coming: Makary

[ Price : $8.95]

Saying that operational consolidations are coming in support services, FDA commissioner Martin Makary asks the staff to view chang...

Sumitomo Gets Fast Track Status for Nuvisertib

[ Price : $8.95]

FDA grants Sumitomo Pharma America a fast track designation for nuvisertib (TP-3654) and its use in treating patients with interme...

CDC, NIH Staff Protest Trump Administration Chaos

[ Price : $8.95]

Current and former CDC employees rally outside the agencys Atlanta headquarters yesterday over Trump Administration-inspired chaos...